Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06245187 · ClinicalTrials.gov registry record
Get With the Guidelines Atrial Fibrillation Registry
A clinical trial of Atrial Fibrillation and Atrial Flutter, sponsored by American Heart Association.
- Recruiting
- Registry status
- 17,198
- Enrollment target
- 1
- Study location
NCT06245187: Recruiting study of Atrial Fibrillation and Atrial Flutter, sponsored by American Heart Association.
NCT06245187 is a study of Atrial Fibrillation and Atrial Flutter that is actively recruiting participants, run by American Heart Association. The registered enrollment target is 17,198 participants, above the 2,912-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (491% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06245187, a study of Atrial Fibrillation and Atrial Flutter, is actively recruiting participants, sponsored by American Heart Association.
- RECRUITING
- Registry status
- 17,198 participants
- Enrollment target
- 1
- Study location
Study Summary
Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.
Primary Outcome
Percent of patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days following ablation procedure.
Conditions Studied
Interventions
- OTHER GWTG Atrial Fibrillation program
Study Locations (1)
Texas
- Amy Bennett - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,198 participants |
| Start Date | 2013-01 |
| Est. Completion | 2040-01 |
What NCT06245187 shows while recruiting
NCT06245187 is an observational study that tracks outcomes without assigning an intervention. Its 17,198 participants enrollment target places it among the larger protocols in the corpus, above the 2,912-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (491% higher).
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which GWTG Atrial Fibrillation program is the first listed.
NCT06245187 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06245187 about?
NCT06245187 is a clinical study titled "Get With the Guidelines Atrial Fibrillation Registry". Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for contin...
What is the current status of trial NCT06245187?
This trial is currently recruiting. The enrollment target is 17,198 participants. The study started on 2013-01. Estimated completion is 2040-01.
What conditions does trial NCT06245187 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter.
What interventions are being tested in trial NCT06245187?
The interventions under investigation include: GWTG Atrial Fibrillation program (OTHER).
Who is sponsoring clinical trial NCT06245187?
This trial is sponsored by American Heart Association, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06245187 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06245187's enrollment target sits among peer trials
17,198 8th of 202 higher than 195 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06479447 · 17,000 participants · NA
Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder
- NCT06272110 · 17,500 participants
Promoting Equitable Access to Language Services in Health and Human Services
- NCT06948838 · 16,895 participants · NA
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
- NCT07290361 · 17,587 participants · NA
Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia